GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Selling and Marketing Expense

Novartis India (BOM:500672) Selling and Marketing Expense : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Novartis India's Selling and Marketing Expense for the three months ended in Mar. 2024 was ₹0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Novartis India Selling and Marketing Expense Historical Data

The historical data trend for Novartis India's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Selling and Marketing Expense Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 539.90 397.70 356.60 279.80 158.70

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novartis India Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis India Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Novartis India's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis India Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Selling and Marketing Expense
Comparable Companies
BOM:500288 BOM:590006 BOM:506879 BOM:530199 BOM:524669 BOM:530239 BOM:543389 BOM:539872 NSE:RPGLIFE BOM:539561 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Website
https://www.novartis.in
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India Headlines

No Headlines